A Propensity-Matched Study of Hypertension and Increased Stroke-Related Hospitalization in Chronic Heart Failure

American Journal of Cardiology

Volumn 101, Issue 12, 2008, Pages 1772-1776

  Filippatos, Gerasimos S ^a   Adamopoulos, Chris ^b   Sui, Xuemei ^c   Love, Thomas E ^d   Pullicino, Patrick M ^e   Lubsen, Jacobus ^f   Bakris, George ^g   Anker, Stefan D ^h   Howard, George ⁱ   Kremastinos, Dimitrios T ^a   Ahmed, Ali ^i,j  

^a UNIVERSITY OF ATHENS   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF KENT   (United Kingdom)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF CHICAGO   (United States)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j BIRMINGHAM VA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CALCULATION; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; STROKE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ALABAMA; BLOOD PRESSURE; CARDIOTONIC AGENTS; CHRONIC DISEASE; DIGITALIS GLYCOSIDES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERTENSION; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MORBIDITY; PREVALENCE; PROGNOSIS; RISK FACTORS; STROKE; SURVIVAL RATE;

EID: 44949083522     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.02.071     Document Type: Article

References (30)

1. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 229 (1974) 409-418
2. Kannel W.B., Wolf P.A., McGee D.L., Dawber T.R., McNamara P., and Castelli W.P. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA 245 (1981) 1225-1229
3. Alla F., Zannad F., and Filippatos G. Epidemiology of acute heart failure syndromes. Heart Fail Rev 12 (2007) 91-95
4. Wolf P.A., Kannel W.B., and McNamara P.M. Occult impaired cardiac function, congestive heart failure, and risk of thrombotic stroke: the Framingham study. Neurology 20 (1970) 373
5. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
6. Collins J.F., Howell C.L., and Horney R.A. Determination of vital status at the end of the DIG trial. Control Clin Trials 24 (2003) 726-730
7. Rosenbaum P.R., and Rubin D.B. The central role of propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
8. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 757-763
9. Rubin D.B. Using propensity score to help design observational studies: application to the tobacco litigation. Health Serv Outcome Res Meth 2 (2001) 169-188
10. Ahmed A. A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol 99 (2007) 549-553
11. Ahmed A., Husain A., Love T.E., Gambassi G., Dell'Italia L.J., Francis G.S., Gheorghiade M., Allman R.M., Meleth S., and Bourge R.C. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
12. Ahmed A., Perry G.J., Fleg J.L., Love T.E., Goff Jr. D.C., and Kitzman D.W. Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J 152 (2006) 956-966
13. Ahmed A., Rich M.W., Sanders P.W., Perry G.J., Bakris G.L., Zile M.R., Love T.E., Aban I.B., and Shlipak M.G. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 99 (2007) 393-398
14. Ahmed A., Zannad F., Love T.E., Tallaj J., Gheorghiade M., Ekundayo O.J., and Pitt B. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28 (2007) 1334-1343
15. Rosenbaum P.R. Observational Studies (2002), Springer-Verlag, New York
16. SPSS. SPSS for Windows, Rel. 15 (2007), SPSS Inc, Chicago, IL
17. Pullicino P.M., Halperin J.L., and Thompson J.L. Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology 54 (2000) 288-294
18. Dries D.L., Rosenberg Y.D., Waclawiw M.A., and Domanski M.J. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 29 (1997) 1074-1080
19. Cleland J.G., Ghosh J., Freemantle N., Kaye G.C., Nasir M., Clark A.L., and Coletta A.P. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 6 (2004) 501-508
20. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., Hoes A., Jaarsma T., Korewicki J., Levy S., Linde C., Lopez-Sendon J.L., Nieminen M.S., Pierard L., and Remme W.J. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
21. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W., Antman E.M., Smith Jr. S.C., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Jacobs A.K., Nishimura R., Ornato J.P., Page R.L., and Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
22. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 247 (1982) 633-638
23. Dahlof B., Lindholm L.H., Hansson L., Schersten B., Ekbom T., and Wester P.O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 338 (1991) 1281-1285
24. Hansson L., Lindholm L.H., Ekbom T., Dahlof B., Lanke J., Schersten B., Wester P.O., Hedner T., and de Faire U. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354 (1999) 1751-1756
25. Lubsen J., Voko Z., Poole-Wilson P.A., Kirwan B.A., and de Brouwer S. Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions. J Clin Epidemiol 60 (2007) 720-726
26. Ekbom T., Dahlof B., Hansson L., Lindholm L.H., Oden A., Schersten B., and Wester P.O. The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure-insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Blood Press 1 (1992) 168-172
27. Laragh J.H. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke). J Hum Hypertens 9 (1995) 385-390
28. Papademetriou V., Farsang C., Elmfeldt D., Hofman A., Lithell H., Olofsson B., Skoog I., Trenkwalder P., and Zanchetti A. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). J Am Coll Cardiol 44 (2004) 1175-1180
29. Iadecola C., and Gorelick P.B. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke 35 (2004) 348-350
30. Benetos A., Adamopoulos C., Bureau J.M., Temmar M., Labat C., Bean K., Thomas F., Pannier B., Asmar R., Zureik M., Safar M., and Guize L. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105 (2002) 1202-1207